Greenlight Biosciences, a developer of RNA-based solutions for agriculture and pharmaceutical applications, has acquired the rights to portions of Bayer’s topical RNA intellectual property portfolio. These assets include bee health capabilities to protect against Varroa mites, a major threat to honeybees. The RNA-based Varroa mite control advance allows for direct targeting of the Varroa mite, without harming the honeybee.